Clearmind Medicine (CMND) Competitors $1.03 0.00 (0.00%) Closing price 07/25/2025 04:00 PM EasternExtended Trading$1.04 +0.01 (+1.46%) As of 07/25/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CMND vs. BCAB, SYBX, RLYB, RVPH, LEXX, BLRX, CYCC, VYNE, DRRX, and HOTHShould you be buying Clearmind Medicine stock or one of its competitors? The main competitors of Clearmind Medicine include BioAtla (BCAB), Synlogic (SYBX), Rallybio (RLYB), Reviva Pharmaceuticals (RVPH), Lexaria Bioscience (LEXX), BioLineRx (BLRX), Cyclacel Pharmaceuticals (CYCC), VYNE Therapeutics (VYNE), DURECT (DRRX), and Hoth Therapeutics (HOTH). These companies are all part of the "pharmaceutical products" industry. Clearmind Medicine vs. Its Competitors BioAtla Synlogic Rallybio Reviva Pharmaceuticals Lexaria Bioscience BioLineRx Cyclacel Pharmaceuticals VYNE Therapeutics DURECT Hoth Therapeutics BioAtla (NASDAQ:BCAB) and Clearmind Medicine (NASDAQ:CMND) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, profitability, analyst recommendations and earnings. Do analysts recommend BCAB or CMND? BioAtla currently has a consensus target price of $5.00, indicating a potential upside of 1,309.24%. Given BioAtla's stronger consensus rating and higher probable upside, equities analysts clearly believe BioAtla is more favorable than Clearmind Medicine.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioAtla 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Clearmind Medicine 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is BCAB or CMND more profitable? Clearmind Medicine's return on equity of -164.79% beat BioAtla's return on equity.Company Net Margins Return on Equity Return on Assets BioAtlaN/A -373.47% -116.55% Clearmind Medicine N/A -164.79%-71.12% Do insiders and institutionals believe in BCAB or CMND? 77.2% of BioAtla shares are owned by institutional investors. Comparatively, 96.1% of Clearmind Medicine shares are owned by institutional investors. 11.5% of BioAtla shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the media refer more to BCAB or CMND? In the previous week, Clearmind Medicine had 1 more articles in the media than BioAtla. MarketBeat recorded 2 mentions for Clearmind Medicine and 1 mentions for BioAtla. BioAtla's average media sentiment score of 1.87 beat Clearmind Medicine's score of 0.93 indicating that BioAtla is being referred to more favorably in the media. Company Overall Sentiment BioAtla Very Positive Clearmind Medicine Positive Which has more volatility and risk, BCAB or CMND? BioAtla has a beta of 0.91, suggesting that its share price is 9% less volatile than the S&P 500. Comparatively, Clearmind Medicine has a beta of 0.93, suggesting that its share price is 7% less volatile than the S&P 500. Which has stronger earnings & valuation, BCAB or CMND? Clearmind Medicine has lower revenue, but higher earnings than BioAtla. Clearmind Medicine is trading at a lower price-to-earnings ratio than BioAtla, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioAtla$11M1.88-$69.78M-$1.22-0.29Clearmind MedicineN/AN/A-$5.26M-$1.10-0.94 SummaryBioAtla and Clearmind Medicine tied by winning 7 of the 14 factors compared between the two stocks. Get Clearmind Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for CMND and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CMND and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CMND vs. The Competition Export to ExcelMetricClearmind MedicineMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.39M$2.49B$5.70B$9.50BDividend YieldN/A1.65%4.58%4.00%P/E Ratio-0.949.1828.3920.08Price / SalesN/A609.56430.4988.77Price / CashN/A165.2136.2258.56Price / Book1.415.168.675.88Net Income-$5.26M$30.99M$3.25B$258.89M7 Day Performance3.00%7.73%4.30%3.71%1 Month Performance16.83%16.27%10.57%11.72%1 Year Performance-42.46%-1.88%35.68%18.00% Clearmind Medicine Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CMNDClearmind Medicine0.897 of 5 stars$1.03flatN/A-37.6%$4.39MN/A-0.94N/ABCABBioAtla2.1616 of 5 stars$0.34+1.6%$5.00+1,365.0%-79.1%$19.63M$11M-0.2860Positive NewsSYBXSynlogic1.2955 of 5 stars$1.60-4.4%N/A-5.4%$19.58M$10K-0.6480Positive NewsHigh Trading VolumeRLYBRallybio2.8594 of 5 stars$0.49+5.6%$10.00+1,947.9%-62.5%$19.24M$640K-0.4540RVPHReviva Pharmaceuticals3.3761 of 5 stars$0.41+3.9%$9.00+2,091.4%-62.6%$18.98MN/A-0.525Positive NewsGap UpLEXXLexaria Bioscience2.2378 of 5 stars$0.97+1.6%$5.00+415.5%-68.3%$18.67M$460K-1.457BLRXBioLineRx2.7988 of 5 stars$4.49+3.0%$26.00+479.1%-87.8%$18.58M$28.94M-0.5140CYCCCyclacel Pharmaceuticals1.1649 of 5 stars$10.76-7.7%N/A-96.0%$18.48M$40K-0.0114Gap DownVYNEVYNE Therapeutics2.934 of 5 stars$1.12-7.4%$6.25+458.0%-30.5%$18.40M$605K-1.1330Positive NewsHigh Trading VolumeDRRXDURECT1.179 of 5 stars$0.55-2.7%N/A-65.6%$17.54M$2.03M-3.6780Positive NewsGap DownHOTHHoth Therapeutics2.9149 of 5 stars$1.32flat$4.00+203.0%+58.0%$17.44MN/A-1.164Analyst Forecast Related Companies and Tools Related Companies BCAB Competitors SYBX Competitors RLYB Competitors RVPH Competitors LEXX Competitors BLRX Competitors CYCC Competitors VYNE Competitors DRRX Competitors HOTH Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CMND) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredURGENT: Trump Could Buy 1,000,000 Bitcoins TOMORROW?According to one report, senior officials and crypto insiders recently discussed Bitcoin accumulation at the h...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clearmind Medicine Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clearmind Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
